AstraZeneca (LON:AZN) Given New £150 Price Target at Berenberg Bank
AstraZeneca (LON:AZN – Get Free Report) had its price target dropped by analysts at Berenberg Bank from £160 to £150 in a report issued on Tuesday, London Stock Exchange reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Berenberg Bank’s price objective indicates a potential upside of 24.23% from the company’s […]
Wizz Air (LON:WIZZ) Price Target Cut to GBX 1,000 by Analysts at Deutsche Bank Aktiengesellschaft
Wizz Air (LON:WIZZ – Get Free Report) had its target price decreased by analysts at Deutsche Bank Aktiengesellschaft from GBX 1,200 to GBX 1,000 in a research note issued on Tuesday, Digital Look reports. The firm presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of […]
Cerillion (LON:CER) Price Target Cut to GBX 1,200 by Analysts at Deutsche Bank Aktiengesellschaft
Cerillion (LON:CER – Get Free Report) had its price objective reduced by investment analysts at Deutsche Bank Aktiengesellschaft from GBX 1,400 to GBX 1,200 in a report issued on Tuesday, Digital Look reports. The firm currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 55.84% […]
Equities Research Analysts’ Price Target Changes for September 15th (ABOS, AU, AXR, AZN, BARC, BBNX, BLKB, BNTC, BWIN, CAKE)
Equities Research Analysts’ price target changes for Tuesday, September 15th: Acumen Pharmaceuticals (NASDAQ:ABOS) had its price target increased by Citigroup Inc. from $4.00 to $5.00. Citigroup Inc. currently has a buy rating on the stock. AngloGold Ashanti (NYSE:AU) had its target price increased by JPMorgan Chase & Co. from $134.00 to $140.00. They currently have […]
Stock Analysts’ Price Target Changes for September 15th (AGF.B, BBNX, BCE, BCF, CGX, CGY, CSHR, ELF, ENB, ET)
Stock Analysts’ price target changes for Tuesday, September 15th: AGF Management (TSE:AGF.B) had its price target cut by TD from C$24.00 to C$23.00. They currently have a buy rating on the stock. Beta Bionics (NASDAQ:BBNX) had its price target boosted by Bank of America Corporation from $18.00 to $20.00. They currently have a neutral rating […]
last updated on 15 Sep 22:57